Max Healthcare Institute Limited (NSE:MAXHEALTH)
India · Delayed Price · Currency is INR 927.15
+31.65 (3.53%)
Nov 4, 2026, 3:29 PM IST
Max Healthcare Institute Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 13,806 | 14,424 | 10,759 | 10,576 | 11,035 | 6,051 |
Depreciation & Amortization | 4,952 | 4,381 | 3,519 | 2,379 | 2,252 | 2,138 |
Other Amortization | 83.9 | 83.9 | 75 | 70.6 | 69.5 | 73 |
Loss (Gain) From Sale of Assets | -8.5 | -6.5 | -1.1 | -4.5 | -13.3 | 30.6 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.6 |
Stock-Based Compensation | 501.6 | 483.3 | 545.9 | 496.2 | 343.6 | 339.3 |
Provision & Write-off of Bad Debts | 757.7 | 471.6 | 250.6 | 109.8 | 74.1 | 92.4 |
Other Operating Activities | 1,481 | -877.8 | 478.1 | -818.8 | -2,477 | -14 |
Change in Accounts Receivable | -3,534 | -3,231 | -2,091 | -1,087 | 647.4 | 29.1 |
Change in Inventory | -143 | -87.3 | -192 | 59 | -148.7 | -75.6 |
Change in Accounts Payable | 1,150 | 732.9 | 811.7 | -402.6 | 987.3 | -447.8 |
Change in Other Net Operating Assets | -739.2 | -41.2 | 224.1 | -161.7 | 70.9 | -811.1 |
Operating Cash Flow | 18,307 | 16,333 | 14,380 | 11,217 | 12,841 | 7,405 |
Operating Cash Flow Growth | 17.72% | 13.59% | 28.20% | -12.65% | 73.41% | 528.31% |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -12,349 | -14,845 | -9,445 | -7,860 | -3,356 | -5,533 |
Sale of Property, Plant & Equipment | 181.4 | 160.5 | 64.1 | 63.4 | 39.2 | 51.7 |
Cash Acquisitions | - | - | -6,247 | -6,300 | -4.8 | -1,072 |
Divestitures | 200 | 406.6 | - | - | - | - |
Investment in Securities | -3,838 | -25.7 | -7.7 | -12.6 | - | -1,712 |
Other Investing Activities | 1,166 | 1,044 | 1,979 | 1,254 | 1,949 | 742.2 |
Investing Cash Flow | -17,305 | -16,890 | -16,107 | -12,855 | -1,023 | -7,638 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 284.5 | 23 | 141.5 | - | 202.8 |
Long-Term Debt Issued | - | 5,393 | 13,472 | 6,279 | 70.7 | 365.6 |
Total Debt Issued | 7,054 | 5,677 | 13,495 | 6,420 | 70.7 | 568.4 |
Short-Term Debt Repaid | - | - | - | - | -289.5 | - |
Long-Term Debt Repaid | - | -1,699 | -12,273 | -6,223 | -1,967 | -2,637 |
Lease Payments | -287.7 | -260.9 | -1,736 | -583.7 | -568.4 | -141.2 |
Total Debt Repaid | -3,292 | -1,699 | -12,273 | -6,223 | -2,257 | -2,637 |
Net Debt Issued (Repaid) | 3,762 | 3,978 | 1,222 | 197.6 | -2,186 | -2,069 |
Issuance of Common Stock | 382.3 | 338.2 | 2.3 | 9.9 | 13.1 | 36.6 |
Common Dividends Paid | -1,944 | -1,456 | -1,456 | -970.1 | - | - |
Other Financing Activities | -2,420 | -2,268 | -1,400 | -1,875 | -712.7 | -909.5 |
Financing Cash Flow | -219.9 | 592.7 | -1,632 | -2,637 | -2,886 | -2,942 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | 4.2 | 6.2 | 1.2 | -18.2 | 1.1 | - |
Miscellaneous Cash Flow Adjustments | - | - | 175.1 | 347.2 | - | - |
Net Cash Flow | 786.5 | 42.2 | -3,183 | -3,946 | 8,934 | -3,175 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 5,958 | 1,488 | 4,935 | 3,357 | 9,485 | 1,872 |
Free Cash Flow Growth | 181.10% | -69.85% | 46.99% | -64.61% | 406.74% | - |
Free Cash Flow Margin | 6.51% | 1.78% | 7.02% | 6.21% | 20.79% | 4.75% |
Free Cash Flow Per Share | 6.10 | 1.52 | 5.05 | 3.44 | 9.76 | 1.93 |
Levered Free Cash Flow | 2,001 | -2,247 | 5,519 | 2,974 | 7,946 | 655.69 |
Unlevered Free Cash Flow | 3,571 | -902.5 | 6,449 | 3,253 | 8,391 | 1,218 |
Free Cash Flow After Leases | 5,670 | 1,227 | 3,199 | 2,774 | 8,917 | 1,731 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 685 | 540.3 | 444.7 | 1,874 | 713.2 | 909.5 |
Cash Income Tax Paid | 3,459 | 3,719 | 3,209 | 2,693 | 1,611 | 1,091 |
Change in Working Capital | -3,266 | -2,627 | -1,247 | -1,592 | 1,557 | -1,305 |